JSC R-PHARM Bevacizumab Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Bevacizumab from India and how much does JSC R-PHARM import?

India exports Bevacizumab to 346 buyers globally worth $8.4M. JSC R-PHARM imports $2.5M (5.4% market share) with 51 shipments from RUSSIA.

Q: What is the average order value for JSC R-PHARM's Bevacizumab imports?

JSC R-PHARM's average Bevacizumab order value is $50.0K per consignment, based on 51 shipments totaling $2.5M.

Q: Who supplies Bevacizumab to JSC R-PHARM?

JSC R-PHARM sources Bevacizumab from 1 verified supplier: DR.REDDY'S LABORATORIES LIMITED ($2.5M, 100.0%). Based on 51 customs records.

Q: How does JSC R-PHARM compare to other Bevacizumab importers?

JSC R-PHARM ranks #1 among 346 Bevacizumab importers from India with 5.4% market share and 51 shipments.

Q: Who are the top Bevacizumab importers from India?

Top Bevacizumab importers: JSC R-PHARM ($2.5M), SEAN DOMINICAN SRL ($1.0M), DR.REDDYS LABORATORIES SAS ($1.0M), BIOCON BIOLOGICS UK LIMITED ($900.0K), JSC R PHARM ($750.0K).

Suresh Sormare

Bevacizumab

India Pharmaceutical Trade Intelligence

$46.9M196 Suppliers100 CountriesHS 30021500

ExportsIndia → RUSSIA50.3%India → NETHERLANDS14.3%

ImportsSWITZERLAND → India$1.2B GERMANY → India$344.1M

#1 Buyer: JSC R-PHARM

JSC R-PHARM — Bevacizumab Importer #1 | $2.5M Trade Value | TransData Nexus | TransData Nexus

JSC R-PHARM — Bevacizumab Importer Profile

Pharmaceutical Importer · #1 buyer for Bevacizumab · $2.5M import value · 51 shipments · RUSSIA · DGFT Verified

JSC R-PHARM is the #1 importer of Bevacizumab from India with $2.5M in import value and 51 verified shipments. JSC R-PHARM holds a 5.4% market share in Bevacizumab imports based in RUSSIA. The company sources from 1 verified supplier across 28 formulations shipped to 1 country. Overall, JSC R-PHARM imports 2 pharmaceutical products worth $3.9M across 1 therapeutic categories.

JSC R-PHARM — Bevacizumab Import Profile: Suppliers, Formulations & Sources

JSC R-PHARM — Bevacizumab import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Bevacizumab to JSC R-PHARM?

Verified from 51 customs shipment records

Supplier	Value	Shipments	% Share
DR.REDDY'S LABORATORIES LIMITED	$2.5M	51	100.0%

JSC R-PHARM sources Bevacizumab from 1 verified Indian supplier based on 51 customs records. The primary supplier is DR.REDDY'S LABORATORIES LIMITED accounting for 100.0% of imports.

How Does JSC R-PHARM Compare to Nearest Bevacizumab Importers?

Buyers ranked immediately above and below #1 by import value

#	Buyer	Country

Where Does JSC R-PHARM Import Bevacizumab To?

Destination countries from 51 verified shipments

Country	Value	Shipments	Share
RUSSIA	$2.5M	51	100.0%

JSC R-PHARM imports Bevacizumab to 1 country. The primary destination is RUSSIA receiving 100.0% of shipments worth $2.5M.

What Bevacizumab Formulations Does JSC R-PHARM Import?

Formulation	Value	Shipments
BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CO	$1.1M	22
BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 34.0 MG/ML WITH BUFFER SOLUTION 28,404 L(QTY:965.736 GMS)	$100.0K	2
BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 36.0 MG/ML WITH BUFFER SOLUTION 28,040 L(QTY:1009.440 GMS)	$100.0K	2
BEVACIZUMAB WCB(QTY:2 VIALS)(NET WEIGHT:2 GMS)	$50.0K	1
BEVACIZUMAB WCB(WORKING CELL BANK)(QTY:3VIALS)	$50.0K	1
BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 33.0 MG/ML WITH BUFFER SOLUTION 26,284 L(QTY:867.372 GMS)	$50.0K	1
BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 33.0 MG/ML WITH BUFFER SOLUTION 27,050 L(QTY:892.650 GMS)	$50.0K	1
BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 34.0 MG/ML WITH BUFFER SOLUTION 25,207 L(QTY:857.038 GMS)	$50.0K	1
BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 36.0 MG/ML WITH BUFFER SOLUTION 28,142 L(QTY:1013.112 GMS)	$50.0K	1
BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 33.0 MG/ML WITH BUFFER SOLUTION 28,906 L(QTY:953.898 GMS)	$50.0K	1

JSC R-PHARM imports 28 distinct Bevacizumab formulations from India. The top formulation is BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CO with 22 shipments worth $1.1M.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Bevacizumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: JSC R-PHARM matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as JSC R-PHARM's capped import value divided by total capped export value for Bevacizumab across all Indian exporters.
5.Verified Records: This page is backed by 51 individual customs records matching JSC R-PHARM importing Bevacizumab, covering 28 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 100+ countries, 346+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Bevacizumab

Bevacizumab

JSC R-PHARM — Bevacizumab Importer Profile

JSC R-PHARM — Bevacizumab Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Bevacizumab to JSC R-PHARM?

How Does JSC R-PHARM Compare to Nearest Bevacizumab Importers?

Where Does JSC R-PHARM Import Bevacizumab To?

What Bevacizumab Formulations Does JSC R-PHARM Import?

Who Are the Top Buyers of Bevacizumab from India and How Much Does JSC R-PHARM Import?

What Is the Average Order Value for JSC R-PHARM's Bevacizumab Imports?

Who Supplies Bevacizumab to JSC R-PHARM?

How Does JSC R-PHARM Compare to Other Bevacizumab Importers?

What Other Advanced Oncology Products Does JSC R-PHARM Import?

About JSC R-PHARM

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Bevacizumab Import Data for JSC R-PHARM

JSC R-PHARM × Bevacizumab

Company Overview

Top Products by JSC R-PHARM

Related Analysis

Need Detailed Import Data?

Data Source

1	JSC R-PHARM ★	RUSSIA	$2.5M	51	$50.0K
7	SEAN DOMINICAN SRL	DOMINICAN REPUBLIC	$1.0M	30	$33.6K
5	DR.REDDYS LABORATORIES SAS	COLOMBIA	$1.0M	20	$50.0K